Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GOSS
#3275
Gossamer Bio, Inc. Common Stock
0.4
2
+7.69%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+7.69%
Mudança mensal
-84.33%
Mudança em 6 meses
-83.00%
Mudança anual
-63.16%
Fechamento anterior
0.3
9
Open
0.4
2
Bid
Ask
Low
0.4
2
High
0.4
3
Volume
101
Mercados
Ações
Cuidados de saúde
GOSS
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
75.53 M
76.48 M
94.98 M
225.58 M
227.22 M
—
Valuation ratios
Enterprise value
244.3 M
681.55 M
81.8 M
186.71 M
159.47 M
1.23 B
Price to earnings ratio
—
-3.61
-0.75
-0.82
-3.62
-14.5
Price to sales ratio
—
—
—
203.92
1.78
24.25
Price to cash flow ratio
—
-4.48
-0.92
-0.93
-59.01
-37.89
Price to book ratio
—
6.97
14.29
2.36
6.94
11.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.45
0.68
0.84
0.58
0.18
0.63
Return on equity %
0.76
1.93
18.99
2.86
1.92
8.4
Return on invested capital %
3 387.39
2 497.3
2 002.56
2 122.48
844.13
—
Gross margin %
100
—
—
100
100
400
Operating margin %
91.39 K
—
—
25.31 K
52.24
353.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
95.06 K
—
—
24.77 K
49.28
1 418.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
13.51
8.32
5.32
5.94
6.88
20.28
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0.37
0.16
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.05
0.08
0.04
0
0
—
Long term debt to total equity ratio
0.09
0.24
0.99
0.01
0
—
Per share metrics
Operating cash flow per share
—
2.52
2.21
1.04
0.02
0.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.35
3.02
1.94
1.3
6.75
Net current asset value per share
—
4.43
3.1
2.01
1.37
4.52
Tangible book value per share
—
1.62
0.14
0.41
0.13
0.72
Working capital per share
—
3.9
2.51
1.67
1.17
3.6
Book value per share
—
1.62
0.14
0.41
0.13
0.72
Notícias
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
Wedbush rebaixa ações da Gossamer Bio após resultados de ensaio clínico
Gossamer Bio stock downgraded by Wedbush on trial results
Barclays rebaixa ação da Gossamer Bio após resultados de ensaio clínico
Barclays cuts Gossamer Bio stock rating on trial results
Leerink rebaixa ações da Gossamer Bio após falha em ensaio clínico
Leerink cuts Gossamer Bio stock rating on trial miss
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%
E.U.A. - Ações fecharam o pregão em queda e o Índice Dow Jones Industrial Average recuou 1,66%
Tesla, Oracle among market cap stock movers on Monday